LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Louisiana LA
Legislatures
2020 Regular Session
House
Bills
HB291
LA
Louisiana House Bill HB291
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Louisiana 2020 Regular Session
Louisiana House Bill HB291
Introduced
2/26/20
Introduced
2/26/20
Refer
2/26/20
Refer
3/9/20
Refer
3/9/20
Caption
Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel
Latest LA HB291 Activity
View All Events: LA 2020 Regular Session HB291
Companion Bills
No companion bills found.
Previously Filed As
LA HB316
Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel (EN +$187,717 GF EX See Note)
LA HB122
Provides relative to the mandatory screening of all newborns for early detection of the cytomegalovirus (CMV) (OR NO IMPACT See Note)
LA HB200
Provides relative to newborn screening for certain genetic conditions (EN SEE FISC NOTE GF EX See Note)
LA HB283
Requires screening of newborns for Krabbe disease (EN +$798,907 GF EX See Note)
LA HCR34
Provides for the potential addition of mucopolysaccharidosis type I and Pompe disease to the state's newborn screening panel
LA HB2798
Relating to requiring the Health Department to mandate mucopolysaccharidosis type 1 (MPS1) test for newborn babies, to be known as Embie’s Law
LA SB105
AN ACT relating to newborn and infant screenings.
LA HB374
AN ACT relating to newborn and infant screenings.
LA HB157
Requires all newborns to be screened for adrenoleukodystrophy
LA HCR33
Requests a study concerning potential inclusion in the state's newborn screening panel of all disorders listed on the federal Recommended Uniform Screening Panel
Similar Bills
No similar bills found.